News Search Results
Oct 16, 2025, 05:00 ET Peptilogics Raises $78 Million to Advance Zaloganan Into Pivotal Trial
PITTSBURGH, Oct. 16, 2025 /PRNewswire/ -- Peptilogics, a clinical-stage biotechnology company developing transformative surgical therapeutics to effectively treat and prevent serious medical device infections, today announced the
More news about: Peptilogics
Oct 15, 2025, 23:43 ET VTT identifies new plant-based anti-inflammatory and anti-ageing ingredients for sustainable cosmetics
cosmetic ingredients with scientifically validated biological activity and efficacy. To achieve this, InnCoCells combined advanced plant science, biotechnology, and cultivation methods - including greenhouse, aeroponic and plant cell culture technologies - with circular approaches such as the upcycling
More news about: VTT Info
Oct 15, 2025, 22:27 ET Stockholder Alert: Robbins LLP Informs MoonLake Immunotherapeutics Stockholders that a Class Action Lawsuit was Filed Against the Company
acquired MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025. MoonLake is a Swiss clinical-stage biotechnology company focused on inflammatory diseases driven by interleukin-17 (IL-17), particularly in dermatology and rheumatology.
More news about: Robbins LLP
Oct 15, 2025, 17:44 ET Veterinary Industry Leader Dr. Stephen Fisher Joins Anivive Board of Directors
About Anivive Lifesciences Anivive Lifesciences is a pet pharmaceutical company at the forefront of biotechnology, artificial intelligence, and veterinary medicine. Our mission is to transform veterinary healthcare by accelerating the development of novel, affordable
More news about: Anivive Lifesciences Inc.
Oct 15, 2025, 16:00 ET Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative
More news about: Innocan Pharma Corporation
Oct 15, 2025, 16:00 ET Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its patent for LPT-CBD was allowed in Japan and will be officially granted upon completion of the administrative
More news about: Innocan Pharma Corporation
Oct 15, 2025, 13:20 ET Redefining Clinical Success for Sites Through Patient-Centered Support, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 15, 2025, 13:10 ET How Linking Real-World Data Sources Can Unlock the Patient Journey, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 15, 2025, 13:00 ET Introducing ICON Strategic Solutions FSP Services: How This Model Supports Sponsors in Korea, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Oct 15, 2025, 11:43 ET Verb Biotics to Host Prof. Siobhain O'Mahony at SupplySide Global: Exploring the Gut-Brain-Hormone Axis in Menopause
particularly through the lens of sex differences. About Verb BioticsVerb Biotics is a B2B biotechnology company that delivers clinically validated microbiome ingredients to functional food, beverage, dietary supplement, and companion animal brands.
More news about: Verb Biotics
Oct 15, 2025, 10:30 ET Life Science Logistics Market is expected to generate a revenue of USD 236.28 Billion by 2032, Globally, at 8% CAGR: Verified Market Research®
a vital role in ensuring the safe and efficient transportation of sensitive pharmaceuticals, biologics, and medical devices. Growing R&D in biotechnology and the need for secure cold chain systems are boosting market demand worldwide. For a detailed analysis
More news about: Verified Market Research
Oct 15, 2025, 10:30 ET Active Pharmaceutical Ingredients (API) Market worth $198.39 billion by 2030 with 6.6% CAGR | MarketsandMarkets™
standards, which encourage domestic production and foreign investments. Additionally, North America has a strong presence of leading pharmaceutical and biotechnology companies that continuously invest in research and development, driving innovation in synthetic and biotech APIs. The increasing prevalence of chronic
More news about: MarketsandMarkets
Oct 15, 2025, 10:20 ET Healthcare Third-party Logistics Market to Reach $502.6 billion, Globally, by 2034 at 7.8% CAGR: Allied Market Research
Service, Clinical Trial Logistics, and Others), End User (Pharmaceutical Companies, Hospitals and Clinics, Medical Device Manufacturing Companies, Biotechnology Companies, and Others), Medium of Transport (Ground Transportation, Air Cargo, and Ocean Freight), and Supply Chain (Cold Chain Logistics and Non-Cold
More news about: Allied Market Research
Oct 15, 2025, 10:02 ET Advanced Instruments is Now Merged Under the Nova Biomedical Name: One Unified Brand Driving Innovation
About Advanced InstrumentsAdvanced Instruments is a global provider of scientific and analytical instruments for the biotechnology, clinical, and food and beverage industries. For more than 65 years, the company's innovations have helped organizations improve quality of results,
More news about: Nova Biomedical
Oct 15, 2025, 08:39 ET Sherak Launches Biotechnology-Based Luxury Skincare for Women 40+
skincare, combining scientific rigor and elegance to address the evolving skin needs of women's skin in midlife. Sherak, a biotechnology-driven luxury skincare company founded by chemist and former pharmaceutical executive Jennifer Sherak, today announced the official launch of its
More news about: Sherak Skin, LLC
Oct 15, 2025, 08:00 ET Monod Bio Receives Award to Develop a New Diagnostic Test for Preeclampsia using AI-designed Proteins
Monod Bio, a biotechnology company utilizing AI-powered de novo protein design for diagnostic and research applications, announced today that it has received a $750,000 grant
More news about: Monod Bio
Oct 15, 2025, 08:00 ET Ouro Medicines Announces Expansion of Clinical Development for OM336 in Sjögren's Disease and Idiopathic Inflammatory Myopathy
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced the initiation of a multinational
More news about: Ouro Medicines
Oct 15, 2025, 07:05 ET REGENXBIO to Participate in Upcoming Investor Conferences
available for approximately 30 days following the events. ABOUT REGENXBIO Inc. REGENXBIO is a biotechnology company on a mission to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the field
More news about: REGENXBIO Inc.
Oct 15, 2025, 07:00 ET Origin Agritech Executes Northeast China Market Re-Entry with Product Showcase and Technology Seminar
Professor Feng Tian presented gene editing applications developed in collaboration with Origin, demonstrating the Company's continued innovation in biotechnology solutions. The Company launched its Golden Harvest Club and Brand Symbiosis Program in August, designed to strengthen dealer
More news about: Origin Agritech Limited
Oct 15, 2025, 07:00 ET Marengo Therapeutics to Present Key Pipeline Updates at 2025 SITC Annual Meeting and Reveal First Asset from TriSTAR™ Platform Targeting Nectin-4
CAMBRIDGE, Mass., Oct. 15, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapy approaches in oncology and inflammation & immunology (I&I), today announced it will for the first
More news about: Marengo Therapeutics
Oct 15, 2025, 06:45 ET Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Oct 15, 2025, 06:30 ET Digital Health Market Size to Worth USD 2688 Billion by 2035 at 22.55% CAGR | Vantage Market Research
Public PayersPrivate Payers Patients & Consumers Pharmaceutical, Biotechnology, and MedTech Companies Other End Users
More news about: Vantage Market Research
Oct 14, 2025, 20:00 ET Nona Biosciences Appoints Dr. Di Hong as Chief Executive Officer to Drive Technology Innovation and Strategic Growth
CAMBRIDGE, Mass., Oct. 14, 2025 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced the appointment
More news about: Nona Biosciences
Oct 14, 2025, 15:31 ET Health and Wellness Food Market to Reach USD 2,177.10 billion by 2032, Growing At An 9.80% CAGR - Credence Research
Technological Innovation and Functional Food Development The integration of advanced food science, biotechnology, and nutritional research has catalyzed the development of sophisticated functional food products that deliver targeted health benefits beyond basic
More news about: Credence Research Inc.
Oct 14, 2025, 14:31 ET GCC Medical Tourism Market to Reach USD 889.97 million by 2032, Growing At An 10.26% CAGR - Credence Research
BIO International Convention, Saudi Arabia signed several memoranda of understanding between its leading health institutions and international biotechnology organizations. This includes a partnership between King Faisal Specialist Hospital and Research Center and US-based Germfree to localize the manufacturing
More news about: Credence Research Inc.